The Klow blend combines four regenerative and anti‑inflammatory peptides—BPC‑157, GHK‑Cu, KPV, and TB‑500—into a single injectable formulation designed to support clinicians who want broad coverage for tissue recovery, skin quality, and local inflammation control. BPC‑157 and TB‑500 are commonly explored for soft‑tissue and connective‑tissue support, GHK‑Cu for collagen, elastin, and skin/hair health, and KPV (a fragment of alpha‑MSH) for its potential calming effects on local inflammation and barrier integrity.
This 5 mL multidose vial delivers 3 mg BPC‑157, 10 mg GHK‑Cu, 3 mg KPV, and 3 mg TB‑500 per mL, allowing for flexible subcutaneous micro‑dosing strategies under provider guidance. It is typically used within comprehensive programs that also emphasize nutrition, movement, physical therapy, and topical care, positioning Klow as an adjunctive tool for patients focused on skin appearance, joint and tendon comfort, or post‑procedure recovery under medical supervision.
